TARE	Transarterial radioembolization
HCC	Hepatocellular carcinoma
Ho-166	Holmium-166
Y-90	Yttrium-90
Tc-99m MAA	Technetium-99m macroaggregated albumin
OS	Overall survival
PFS	Progression-free survival
HR	Hazard ratio
CI	Confidence interval
BCLC	Barcelona Clinic Liver Cancer
TACE	Transarterial chemoembolization
PVTT	Portal vein tumor thrombosis
ECOG	Eastern Cooperative Oncology Group
CBCT	Cone-beam computed tomography
SPECT/CT	Single-photon emission computed tomography combined with computed tomography
PET/CT	Positron emission tomography combined with computed tomography
MRI	Magnetic resonance imaging
mRECIST	Modified Response Evaluation Criteria in Solid Tumors
ORR	Objective response rate
CR	Complete response
PR	Partial response
CRR	Complete response rate
DoR	Duration of response
SOD	Sum of diameters
ARLD	Alcohol-related liver disease
MASLD	Metabolic dysfunction-associated steatotic liver disease
SD	Standard deviation
IQR	Interquartile range
CIRSE	Cardiovascular and Interventional Radiological Society of Europe